Toboroz
Increasing Germline Genetic Testing for Patients With Cancer
NCT07307664· Josh Peterson· Forrás
Contact: Abby Sokoloff
Toboroz
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide
NCT07040592· 2. fázis· Yale University· Forrás
Contact: Ketteria Ingram
Toboroz
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
NCT06592924· 3. fázis· Canadian Cancer Trials Group· Forrás
Contact: Wayne B. Harris (principal investigator)
Toboroz
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
NCT06616584· 2/3. fázis· SWOG Cancer Research Network· Forrás
Contact: Badi El Osta (principal investigator)
Toboroz
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
NCT06271590· Concept Medical Inc.· Forrás
Contact: Susan Muly
Toboroz
A Study of a Novel EEG Neurofeedback System for PTSD Treatment
NCT06770998· Foundation for Atlanta Veterans Education and Research, Inc.· Forrás
Contact: David Parker, PhD
Toboroz
Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula
NCT06516653· Laminate Medical Technologies· Forrás
Contact: Adriana Gutrierrez Yllu
Toboroz
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
NCT06218875· W.L.Gore & Associates· Forrás
Contact: Elizabeth Tibus
Toboroz
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
NCT05908331· Concept Medical Inc.· Forrás
Contact: Savitha Shivaraj
Toboroz
The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
NCT05811364· W.L.Gore & Associates· Forrás
Contact: Olamine Alabi, MD
Toboroz
Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
NCT05928936· 2. fázis· Emory University· Forrás
Contact: Dana DaCosta
Toboroz
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069· Alliance for Clinical Trials in Oncology· Forrás
Contact: Wayne B. Harris (principal investigator)
Fut, nem toboroz
COVID-19 Outcome Prediction Algorithm
NCT05471011· University of California, Los Angeles· Forrás
Toboroz
Physio-Anatomy Clinical Data Collection Study
NCT05312164· Gentuity, LLC· Forrás
Contact: Gautam Kumar, MD (principal investigator)
Fut, nem toboroz
Changing the Natural History of Type 2 Diabetes ("CHANGE" Study)
NCT05040087· Foundation for Atlanta Veterans Education and Research, Inc.· Forrás
Fut, nem toboroz
Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
NCT04625647· 2. fázis· SWOG Cancer Research Network· Forrás
Fut, nem toboroz
NCI COVID-19 in Cancer Patients, NCCAPS Study
NCT04387656· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer
NCT04155034· 3. fázis· SWOG Cancer Research Network· Forrás
Fut, nem toboroz
Targeted Treatment for RET Fusion-Positive Advanced Non-Small Cell Lung Cancer (A LUNG-MAP Treatment Trial)
NCT04268550· 2. fázis· SWOG Cancer Research Network· Forrás
Fut, nem toboroz
Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer
NCT03811015· 3. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer
NCT03793179· 3. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
Assessing the Ability of Combination Treatment With Venetoclax to Permit Time Limited Therapy in Chronic Lymphocytic Leukemia
NCT03701282· 3. fázis· National Cancer Institute (NCI)· Forrás
Toboroz
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
NCT03851445· 2/3. fázis· SWOG Cancer Research Network· Forrás
Contact: Badi El Osta (principal investigator)
Fut, nem toboroz
Testing the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia
NCT03737981· 3. fázis· National Cancer Institute (NCI)· Forrás
Toboroz
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
NCT03678025· 3. fázis· SWOG Cancer Research Network· Forrás
Contact: Wayne B. Harris (principal investigator)
Fut, nem toboroz
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
NCT03233711· 3. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
NCT03419234· 2. fázis· ECOG-ACRIN Cancer Research Group· Forrás
Fut, nem toboroz
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
NCT03055013· 3. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer
NCT03091660· 3. fázis· SWOG Cancer Research Network· Forrás
Fut, nem toboroz
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT02834013· 2. fázis· National Cancer Institute (NCI)· Forrás
Toboroz
Communication Issues in Patient and Provider Discussions of Immunotherapy
NCT05873608· Emory University· Forrás
Contact: Wayne B. Harris, MD
Fut, nem toboroz
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
NCT02595944· 3. fázis· National Cancer Institute (NCI)· Forrás
Toboroz
Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV
NCT02560805· 2. fázis· Emory University· Forrás
Contact: Deirdre Dixon
Toboroz
Sympatholysis in Chronic Kidney Disease
NCT02411773· 1. fázis· Emory University· Forrás
Contact: Dana DaCosta
Fut, nem toboroz
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
NCT02201992· 3. fázis· ECOG-ACRIN Cancer Research Group· Forrás
Fut, nem toboroz
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
NCT02193282· 3. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
NCT02194738· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
NCT01863550· 3. fázis· ECOG-ACRIN Cancer Research Group· Forrás
Fut, nem toboroz
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
NCT01856192· 2. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer
NCT01708954· 2. fázis· National Cancer Institute (NCI)· Forrás
Toboroz
Sympathetic Overactivity in Post-traumatic Stress Disorder
NCT01627301· Emory University· Forrás
Contact: Deirdre Dixon, MS
Fut, nem toboroz
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
NCT01368588· 3. fázis· Radiation Therapy Oncology Group· Forrás
Fut, nem toboroz
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
NCT01169337· 3. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
NCT00956007· 3. fázis· Radiation Therapy Oncology Group· Forrás
Fut, nem toboroz
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
NCT00588770· 3. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
NCT00499330· Alliance for Clinical Trials in Oncology· Forrás